Tolerability and efficacy of Mycobacterium avium complex pulmonary disease treatment in elderly patients

The two-drug regimen of EB and macrolide without RFP may be a tolerable and effective treatment for elderly MAC-PD patients.

Authors

Institutions

Publication Details

Journal
BMC Pulmonary Medicine
Published
2025-02-07
DOI
https://doi.org/10.1186/s12890-025-03504-4
Citations
2
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tolerability and efficacy of Mycobacterium avium complex pulmonary disease treatment in elderly patients

Kyota Shinfuku, Hiromichi Hara, Hanae Miyagawa, Naoki Takasaka et al.
2 citations
BMC Pulmonary Medicine
Mycobacterium research and diagnosis
2.71
article

Tolerability and efficacy of Mycobacterium avium complex pulmonary disease treatment in elderly patients

Kyota Shinfuku, Hiromichi Hara, Hanae Miyagawa, Naoki Takasaka, Takeo Ishikawa, Jun Araya, Keitaro Okuda
article en
2 citations

Abstract

The two-drug regimen of EB and macrolide without RFP may be a tolerable and effective treatment for elderly MAC-PD patients.

BMC Pulmonary MedicineVol. 25(1)
Jikei University School of Medicine (JP), The Jikei University Hospital (JP)
Good health and well-being
Openalex Percentile: Top 12%
Mycobacterium research and diagnosis
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.